Christin Linderkamp

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study.

Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study.

Journal: Leukemia
Published: May 26, 2025

Wilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening.

Wilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening.

Journal: Translational oncology
Published: September 15, 2024

Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen.

Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen.

Journal: Haematologica
Published: May 14, 2024

Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL.

Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL.

Journal: Leukemia
Published: August 26, 2022

Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

Journal: JAMA
Published: March 02, 2021

Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.

Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.

Journal: Leukemia
Published: September 17, 2019

Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.

Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.

Journal: Clinical epigenetics
Published: August 03, 2019

Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study.

Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: June 06, 2019

Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology.

Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology.

Journal: GMS hygiene and infection control
Published: November 22, 2018

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.

Journal: Haematologica
Published: September 14, 2018

Prevalence and configuration of pulmonary nodules on multi-row CT in children without malignant diseases.

Prevalence and configuration of pulmonary nodules on multi-row CT in children without malignant diseases.

Journal: European radiology
Published: July 10, 2014

Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma.

Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma.

Journal: Pediatric blood & cancer
Published: April 17, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026